Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Berirab P 750IU Injection

Prescription Icon
Prescription Required

Marketer

Zydus Cadila

Salt Composition

Human Rabies Immunoglobulin (750IU)

Overview Berirab P 750IU Injection

Rabies Immunoglobulin (RIG) Berirab P 750IU is a single-dose injection used alongside rabies vaccination to prevent rabies infection in previously unvaccinated individuals. It provides immediate antibody protection against the rabies virus, acting as a crucial component of pre-exposure prophylaxis. Administered intramuscularly by a healthcare professional, this immunoglobulin is always combined with a complete rabies vaccine series. This combined approach – active (vaccine) and passive (RIG) immunization – works by preventing the virus from reaching the central nervous system; however, treatment is ineffective once the virus has breached this barrier. Therefore, prompt administration after potential exposure is vital. Berirab P 750IU is a one-time injection given only once in a person’s lifetime. Common, typically transient, side effects include injection site pain, stiffness, and tenderness; rarely, more serious reactions like anaphylaxis or angioedema (swelling) may occur. Rest may alleviate discomfort, but persistent or concerning symptoms require medical attention. Prior to administration, inform your doctor about any previous immunoglobulin allergies or other medications you are currently taking, as interactions are possible. Pregnant or breastfeeding individuals should also consult their doctor before receiving this injection.

Primary Ingredients of Berirab P 750IU Injection

No text was provided to rewrite. Please provide the text you wish me to rephrase.

Uses of Berirab P 750IU Injection

Avoiding Rabies

Major Benefits of Berirab P 750IU Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Berirab P 750IU Injection:

  • Headache
  • Muscle pain
  • Joint pain
  • Dizziness
  • Fatigue
  • Soreness
  • Fever
  • Pain in extremity
  • Vomiting

How to use Berirab P 750IU Injection:

Administering this medication will be handled by your healthcare provider. Please do not attempt self-medication.

How Berirab P 750IU Injection works:

Berirab P 750IU Injection provides pre-formed antibodies, conferring passive immunity against rabies virus infection.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction between alcohol and Berirab P 750IU Injection is unknown. Medical advice is recommended before combining them.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Berirab P 750IU Injection during pregnancy is typically regarded as safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, data from human studies are scarce.

Breast feedingBreast feedingCAUTION

The administration of Berirab P 750IU Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.

DrivingDrivingSAFE

Driving ability is typically unaffected by Berirab P 750IU Injection.

KidneyKidneySAFE IF PRESCRIBED

Berirab P 750IU Injection appears to pose minimal risk for individuals with kidney impairment. Preliminary findings indicate dose modification may be unnecessary in such cases. Physician consultation is recommended.

LiverLiverSAFE IF PRESCRIBED

Berirab P 750IU Injection appears to be well-tolerated by individuals with hepatic impairment. Existing evidence indicates that dose modification for this medication may not be necessary in such cases. However, physician consultation is recommended.

What if you forget to take Berirab P 750IU Injection :

Should you forget a dose of Berirab P 750IU Injection, seek advice from your physician.

Facts to Know About Berirab P 750IU Injection

LabelValue
Chemical Category Immunizations
Developing Habits No.
Treatment Category Immunizations

FAQs on Berirab P 750IU Injection

Berirab P 750IU Injection is a high-concentration rabies antibody solution offering immediate protection against rabies. It's administered with the first dose of anti-rabies vaccine (ARV) or within seven days of it.
Rabies is entirely preventable. Prompt wound care and immediate treatment with Berirab P 750IU Injection alongside anti-rabies vaccine (ARV) virtually guarantees protection, even following severe exposure.
Patients fully vaccinated against rabies do not need Berirab P 750IU Injection.
Berirab P 750IU Injection pain varies by individual tolerance. Administered near the bite site by a healthcare professional, the injection itself can be uncomfortable. Larger amounts may be needed at the wound site to manage pain and treat infection.
Equine rabies immunoglobulin (ERIG) offers a lower cost than human rabies immunoglobulin (HRIG), such as Berirab P 750IU, making it more accessible to patients in developing nations like India. However, ERIG's greater risk of serious allergic reactions, including anaphylaxis and serum sickness, makes its use less favored by physicians.
Berirab P 750IU Injection delivers a high concentration of rabies antibodies, offering immediate protection against rabies. It's administered concurrently with, or within seven days of, the first anti-rabies vaccine (ARV) dose.
Rabies is entirely preventable. Prompt wound care coupled with immediate treatment using Berirab P 750IU Injection and anti-rabies vaccine (ARV) virtually guarantees protection, even following significant exposure.
Patients fully vaccinated against rabies do not need Berirab P 750IU Injection.
Berirab P 750IU Injection pain levels vary depending on individual pain tolerance. Initial administration by a healthcare professional at the bite site may be uncomfortable. Larger amounts may be needed at the wound site to manage pain and treat infection.
Equine rabies immunoglobulin offers a lower cost alternative to human rabies immunoglobulin (HRIG) like Berirab P 750IU, making it more accessible to patients in developing nations such as India. However, its greater risk of serious allergic reactions, including anaphylaxis and serum sickness, makes physicians reluctant to prescribe it.
Berirab P 750IU Injection
5,184
MRP 5,714
9% off